Older colitis patients fare better

October 2010
Clinical Advisor;Oct2010, Vol. 13 Issue 10, p18
The article reports that remission of ulcerative colitis is more likely to occur to people who develop the disease after the age 50 than those with earlier-onset disease.


Related Articles

  • GI distension in severe ulcerative colitis Latella, Giovanni; Vernia, Piero; Viscido, Angelo; Frieri, Giuseppe; Cadau, Giuseppina; Cocco, Andrea; Cossu, Andrea; Tomei, Ernesto; Caprilli, Renzo // American Journal of Gastroenterology;May2002, Vol. 97 Issue 5, p1169 

    OBJECTIVES:In previous retrospective studies in patients with severe ulcerative colitis (UC), small bowel distension was found to characterize a subgroup of patients at higher risk for both toxic megacolon (TMC) and multiple organ dysfunction syndrome (MODS). In this study we prospectively...

  • Editorial. Hisamatsu, Tadakazu; Hibi, Toshifumi // Journal of Gastroenterology;1998, Vol. 33 Issue 4, p609 

    Editorial. Comments on the use of clyclosprine for inflammatory bowel disease. Case report of a patient with steroid-refractory severe ulcerative colitis responding to intravenous cyclosporine therapy; Issue concerning the maintenance therapy for remission achieved by intravenous cyclosporine...

  • Ulcerative Postdysenteric Colitis. Fung, W. P.; Monteiro, E. H.; Ang, H. B.; Kho, K. M.; Lee, S. K. // American Journal of Gastroenterology;Apr1972, Vol. 57 Issue 4, p341 

    Focuses on chronic bowel symptoms following acute amebic dysentery. Forms of postdysenteric sequels following acute amebic dysentery; Details of several cases of ulcerative postdysenteric colitis detected in Singapore; Differences between ulcerative postdysenteric colitis and chronic...

  • Ulcerative colitis and Crohn's disease. Ferguson, Anne // BMJ: British Medical Journal (International Edition);8/6/94, Vol. 309 Issue 6951, p355 

    Focuses on ulcerative colitis and Crohn's disease. Features of the two diseases; Impact of the medical treatment to the ulceration and fibrosis; Relevance of bowel function and disease.

  • Interleukin (IL)-1 Gene Cluster in Inflammatory Bowel Disease: Is IL-1RA Implicated in the Disease Onset and Outcome? Muro, Manuel; Mrowiec, Anna // Digestive Diseases & Sciences;May2015, Vol. 60 Issue 5, p1126 

    No abstract available.

  • Predictors of Health-Related Quality of Life and Adherence in Crohn's Disease and Ulcerative Colitis: Implications for Clinical Management. Tabibian, Anilga; Tabibian, James; Beckman, Linda; Raffals, Laura; Papadakis, Konstantinos; Kane, Sunanda // Digestive Diseases & Sciences;May2015, Vol. 60 Issue 5, p1366 

    Background and Aims: Inflammatory bowel disease (IBD) is associated with impaired health-related quality of life (HRQOL) and adherence. Our aim was to identify demographic, clinical, and psychosocial predictors of impaired HRQOL and non-adherence to provider recommendations. Methods: Adults with...

  • Environmental Factors in the Relapse and Recurrence of Inflammatory Bowel Disease: A Review of the Literature. Martin, Thomas; Chan, Simon; Hart, Andrew // Digestive Diseases & Sciences;May2015, Vol. 60 Issue 5, p1396 

    Introduction: The causes of relapse in patients with Crohn's disease (CD) and ulcerative colitis (UC) are largely unknown. This paper reviews the epidemiological and clinical data on how medications (non-steroidal anti-inflammatory drugs, estrogens and antibiotics), lifestyle factors (smoking,...

  • Low-FODMAP Diet for Irritable Bowel Syndrome: Is It Ready for Prime Time? Khan, Muhammad; Nusrat, Salman; Nawras, Ali; Bielefeldt, Klaus // Digestive Diseases & Sciences;May2015, Vol. 60 Issue 5, p1169 

    Irritable bowel syndrome (IBS) is a chronic gastrointestinal disease, which adversely affects the quality of life. Its prevalence has been reported to be around 10-15 % in North America and constitutes the most common cause for gastroenterology referral. Unfortunately, the pathophysiology of IBS...

  • LACTOBACILLUS PREVENTS RELAPSE IN ULCERATIVE COLITIS.  // Pulse;8/10/2006, Vol. 66 Issue 31, p25 

    The article focuses on the prevention of relapse in patients with ulcerative colitis through regular treatment with Lactobacillus rhamnosus GG. LGG has been used successfully to treat travellers' diarrhea and antibiotic-associated diarrhea. The evidence for the effectiveness of Lactobacillus...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics